SRRK Insider Transactions
279 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 1–100; provenance stays internal.
SRRK insiders transaction timeline
PurchaseSale
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| FLIER JEFFREY S. | Director | 2026-07-01 | Sale | 15 | $54.8757 |
| FLIER JEFFREY S. | Director | 2026-07-01 | Sale | 1,470 | $54.2365 |
| FLIER JEFFREY S. | Director | 2026-07-01 | Sale | 1,568 | $53.5328 |
| Gilman Michael | Director | 2026-07-01 | Sale | 43 | $54.8145 |
| Gilman Michael | Director | 2026-07-01 | Sale | 1,155 | $54.2257 |
| Gilman Michael | Director | 2026-07-01 | Sale | 1,346 | $53.544 |
| Burow Kristina | Director | 2026-07-01 | Sale | 948 | $54.2816 |
| Burow Kristina | Director | 2026-07-01 | Sale | 2,105 | $53.4940 |
| Reed Joshua | Director | 2026-07-01 | Sale | 948 | $54.2814 |
| Reed Joshua | Director | 2026-07-01 | Sale | 2,105 | $53.4958 |
| Peng Katie | Director | 2026-07-01 | Sale | 21 | $54.9641 |
| Peng Katie | Director | 2026-07-01 | Sale | 2,437 | $54.2526 |
| Peng Katie | Director | 2026-07-01 | Sale | 2,988 | $53.5598 |
| Woods Keith | Chief Operating Officer | 2026-04-16 | Sale | 10,220.0 | $49.57 |
| Vaishnaw Akshay | President of R&D | 2026-04-16 | Sale | 12,246.0 | $49.57 |
| Sinha Vikas | Chief Financial Officer | 2026-04-16 | Sale | 10,410.0 | $49.57 |
| Hallal David | Chief Executive Officer | 2026-04-16 | Sale | 30,615.0 | $49.57 |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | 2026-02-23 | Sale | 200.0 | $48.48 |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | 2026-02-23 | Sale | 857.0 | $47.86 |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | 2026-02-23 | Sale | 7,427.0 | $46.94 |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | 2026-02-17 | Sale | 7,989.0 | $46.53 |
| Parlavecchio Caryn | CHRO | 2026-02-17 | Sale | 9,035.0 | $46.53 |
| Ho Junlin | GENERAL COUNSEL | 2026-02-17 | Sale | 9,580.0 | $46.53 |
| Marantz Jing L. | CHIEF MEDICAL OFFICER | 2026-02-17 | Sale | 4,157.0 | $46.53 |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | 2026-01-22 | Sale | 12,779.0 | $46.85 |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | 2026-01-22 | Sale | 2,119.0 | $45.87 |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | 2026-01-16 | Sale | 8,406.0 | $44.48 |
| Parlavecchio Caryn | CHRO | 2026-01-16 | Sale | 6,600.0 | $44.48 |
| Ho Junlin | GENERAL COUNSEL | 2026-01-16 | Sale | 8,016.0 | $44.48 |
| Marantz Jing L. | CHIEF MEDICAL OFFICER | 2026-01-16 | Sale | 5,798.0 | $44.48 |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | 2026-01-14 | Sale | 13,112.0 | $45.2 |
| Sinha Vikas | Chief Financial Officer | 2026-01-13 | Sale | 16,755.0 | $42.7 |
| Woods Keith | Chief Operating Officer | 2026-01-13 | Sale | 16,746.0 | $42.7 |
| Vaishnaw Akshay | President of R&D | 2026-01-13 | Sale | 20,438.0 | $42.7 |
| Hallal David | Chief Executive Officer | 2026-01-13 | Sale | 57,450.0 | $42.7 |
| Peng Katie | Director | 2025-12-16 | Sale | 280.0 | $44.63 |
| Peng Katie | Director | 2025-12-16 | Sale | 726.0 | $43.88 |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | 2025-12-04 | Sale | 136,462.0 | $45.21 |
| AKKARAJU SRINIVAS | Director | 2025-10-07 | Purchase | 4,403.0 | $40.97 |
| AKKARAJU SRINIVAS | Director | 2025-10-07 | Purchase | 12,400.0 | $40.18 |
| AKKARAJU SRINIVAS | Director | 2025-10-07 | Purchase | 12,796.0 | $39.31 |
| AKKARAJU SRINIVAS | Director | 2025-10-06 | Purchase | 13,748.0 | $39.52 |
| AKKARAJU SRINIVAS | Director | 2025-10-06 | Purchase | 80,863.0 | $38.68 |
| AKKARAJU SRINIVAS | Director | 2025-10-06 | Purchase | 18,414.0 | $37.89 |
| AKKARAJU SRINIVAS | Director | 2025-10-03 | Purchase | 319,700.0 | $37.42 |
| AKKARAJU SRINIVAS | Director | 2025-10-03 | Purchase | 56,703.0 | $36.74 |
| AKKARAJU SRINIVAS | Director | 2025-10-03 | Purchase | 11,011.0 | $35.61 |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | 2025-09-22 | Sale | 3,353.0 | $30.67 |
| Peng Katie | Director | 2025-09-16 | Sale | 76.0 | $33.2 |
| Peng Katie | Director | 2025-09-16 | Sale | 930.0 | $32.48 |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | 2025-09-16 | Sale | 3,178.0 | $33.52 |
| Parlavecchio Caryn | CHRO | 2025-08-18 | Sale | 2,178.0 | $31.17 |
| FLIER JEFFREY S. | Director | 2025-07-16 | Sale | 11,136.0 | $40.02 |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | 2025-07-08 | Sale | 24,066.0 | $34.44 |
| FLIER JEFFREY S. | Director | 2025-06-23 | Sale | 11,136.0 | $33.21 |
| FLIER JEFFREY S. | Director | 2025-06-23 | Sale | 2,766.0 | $32.74 |
| FLIER JEFFREY S. | Director | 2025-06-23 | Sale | 17,550.0 | $32.16 |
| Peng Katie | Director | 2025-06-16 | Sale | 54.0 | $32.53 |
| Peng Katie | Director | 2025-06-16 | Sale | 2,977.0 | $31.96 |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | 2025-06-16 | Sale | 3,668.0 | $32.0 |
| Parlavecchio Caryn | CHRO | 2025-06-16 | Sale | 6,186.0 | $32.0 |
| Ho Junlin | GENERAL COUNSEL | 2025-06-16 | Sale | 7,442.0 | $32.0 |
| FLIER JEFFREY S. | Director | 2025-05-29 | Sale | 4,975.0 | $29.84 |
| FLIER JEFFREY S. | Director | 2025-05-29 | Sale | 1,100.0 | $29.23 |
| Burow Kristina | Director | 2025-05-29 | Sale | 4,400.0 | $29.83 |
| Burow Kristina | Director | 2025-05-29 | Sale | 1,000.0 | $29.24 |
| Gilman Michael | Director | 2025-05-29 | Sale | 2,745.0 | $29.83 |
| Gilman Michael | Director | 2025-05-29 | Sale | 630.0 | $29.22 |
| Brudnick Richard | Director | 2025-05-29 | Sale | 1,400.0 | $30.0 |
| Brudnick Richard | Director | 2025-05-29 | Sale | 4,675.0 | $29.63 |
| Reed Joshua | Director | 2025-05-29 | Sale | 500.0 | $30.04 |
| Reed Joshua | Director | 2025-05-29 | Sale | 4,900.0 | $29.68 |
| Vaishnaw Akshay | President of R&D | 2025-05-29 | Sale | 1,620.0 | $30.01 |
| Vaishnaw Akshay | President of R&D | 2025-05-29 | Sale | 5,130.0 | $29.63 |
| Sacco Tracey | Chief Commercial Officer | 2025-04-25 | Sale | 84.0 | $33.49 |
| Sacco Tracey | Chief Commercial Officer | 2025-04-25 | Sale | 4,916.0 | $32.81 |
| Sacco Tracey | Chief Commercial Officer | 2025-03-24 | Sale | 5,000.0 | $32.89 |
| Sacco Tracey | Chief Commercial Officer | 2025-03-24 | Sale | 1,500.0 | $33.7 |
| Moore Erin | Interim PFO and PAO | 2025-03-24 | Sale | 13,564.0 | $33.12 |
| Peng Katie | Director | 2025-03-17 | Sale | 1,006.0 | $34.42 |
| Myles Edward H | COO & CFO | 2025-03-10 | Sale | 29,395.0 | $34.87 |
| Myles Edward H | COO & CFO | 2025-03-10 | Sale | 112,897.0 | $35.82 |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | 2025-02-19 | Sale | 20,202.0 | $37.74 |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | 2025-02-19 | Sale | 8,341.0 | $37.56 |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | 2025-02-19 | Sale | 39,967.0 | $37.2 |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | 2025-02-18 | Sale | 4,135.0 | $36.83 |
| Parlavecchio Caryn | CHRO | 2025-02-18 | Sale | 5,296.0 | $36.83 |
| Myles Edward H | COO & CFO | 2025-02-18 | Sale | 7,809.0 | $36.83 |
| Ho Junlin | GENERAL COUNSEL | 2025-02-18 | Sale | 5,742.0 | $36.83 |
| Backstrom Jay T. | CHIEF EXECUTIVE OFFICER | 2025-02-18 | Sale | 18,372.0 | $36.83 |
| Backstrom Jay T. | CHIEF EXECUTIVE OFFICER | 2025-01-16 | Sale | 22,308.0 | $44.2 |
| Marantz Jing L. | CHIEF MEDICAL OFFICER | 2025-01-16 | Sale | 5,655.0 | $44.2 |
| Sacco Tracey | Chief Commercial Officer | 2025-01-16 | Sale | 3,890.0 | $44.2 |
| Qatanani Mo | CHIEF SCIENTIFIC OFFICER | 2025-01-16 | Sale | 7,347.0 | $44.2 |
| Parlavecchio Caryn | CHRO | 2025-01-16 | Sale | 6,434.0 | $44.2 |
| Myles Edward H | COO & CFO | 2025-01-16 | Sale | 12,539.0 | $44.2 |
| Ho Junlin | GENERAL COUNSEL | 2025-01-16 | Sale | 9,039.0 | $44.2 |
| DEBBANE RAYMOND | TenPercentOwner | 2024-12-10 | Sale | 1,600,000.0 | $41.65 |
| Invus Public Equities Advisors, LLC | TenPercentOwner | 2024-12-10 | Sale | 1,600,000.0 | $41.65 |
| Invus Public Equities, L.P. | TenPercentOwner | 2024-12-10 | Sale | 1,600,000.0 | $41.65 |